Collaboration between Malaysia and South Korea introduces the most recent cancer treatment, NK cell therapy
Universiti Kebangsaan Malaysia (UKM) and NK Biocell Sdn. Bhd. inked a Memorandum of Agreement (MoA) at the Hospital Universiti Kebangsaan Malaysia (HUKM). As a result of this arrangement, UKM can produce MYJ1633, which is made up of NK cells and NK T cells (NKT Cell). Cancer patients may benefit from its use. There are more…